Original Research
Published on 06 Sep 2021
Yisaipu® Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation
in Drugs Outcomes Research and Policies
- 3,958 views
- 4 citations












